Inotiv (NASDAQ: NOTV) warned on Nasdaq listing over $1 bid price rule
Rhea-AI Filing Summary
Inotiv, Inc. reported that on December 31, 2025 it received a written notice from Nasdaq that its common stock is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share for 30 consecutive business days. The notice does not immediately affect the listing or trading of the common shares on Nasdaq.
Inotiv has 180 calendar days, until June 29, 2026, to regain compliance by having its stock close at or above $1.00 per share for at least 10 consecutive business days, subject to Nasdaq’s discretion to require a longer period. If it fails to do so, the company may be eligible for an additional 180-day grace period. Inotiv plans to monitor its share price and evaluate options, but there is no assurance it will regain or maintain compliance with Nasdaq listing requirements.
Positive
- None.
Negative
- Nasdaq minimum bid price deficiency: Inotiv’s common stock failed to maintain a $1.00 minimum closing bid for 30 consecutive business days, creating a formal risk to its Nasdaq listing if not remedied within the allowed compliance periods.
Insights
Nasdaq bid-price noncompliance raises listing and liquidity risk.
Inotiv, Inc. disclosed that Nasdaq notified the company on December 31, 2025 that its shares no longer meet the $1.00 minimum bid requirement for 30 consecutive business days under Listing Rule 5550(a)(2). The notice leaves the stock currently listed on Nasdaq, but formally flags a deficiency that must be cured.
The company has 180 calendar days, until June 29, 2026, to regain compliance by achieving a closing bid of at least $1.00 for a minimum of 10 consecutive business days, with Nasdaq retaining discretion to require a longer period. If the threshold is not met by that date, Inotiv may qualify for another 180‑day grace period, but this is not guaranteed by the disclosure.
The company states it will monitor its closing bid price and evaluate options to restore compliance. However, it explicitly notes there can be no assurance it will regain compliance within the initial 180‑day period, obtain a second 180‑day period, or continue meeting other Nasdaq listing standards, underscoring a meaningful risk around future listing status and market liquidity.